Primary Peritoneal Carcinoma Terminated Phase 1 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01202890Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian CancerTreatment